NCT03175991

Brief Summary

Ovarian masses are common problems in clinical practice. Sonography is considered the firstline imaging technique for discriminating between malignant and benign lesions, and it has been shown to be useful for determining optimal treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
123

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 29, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 5, 2017

Completed
1.1 years until next milestone

Study Start

First participant enrolled

July 5, 2018

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 26, 2019

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2019

Completed
Last Updated

May 12, 2020

Status Verified

May 1, 2020

Enrollment Period

8 months

First QC Date

May 29, 2017

Last Update Submit

May 9, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • The resistivity index

    The resistive index will be automatically calculated from at least 3 consecutive flow velocity waveforms

    10 minutes

Study Arms (1)

ovarian masses patients

women of different age groups diagnosed as having an ovarian mass or accidentally discovered ovarian mass in non-complaining female by ultrasonography or Patients known to have primary that may give metastasis to the ovaries.

Diagnostic Test: ultrasonography

Interventions

ultrasonographyDIAGNOSTIC_TEST

A morphologic evaluation will be performed according to International Ovarian Tumor Analysis Group recommendations for the following parameters: Bilaterality , wall thickness, septations , papillary projections, solid areas, and echogenicity. The presence of ascites also will be recorded. Pattern recognition analysis will be used for ovarian masses highly suggestive of some diseases , then color Doppler will be activated to identify vascular color signals within the lesion.

ovarian masses patients

Eligibility Criteria

Sexfemale
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study will included 123 females Who referred to radiodiagnosis department at South Egypt Cancer Institute of different ages ,diagnosed as having ovarain mass

You may qualify if:

  • All women of different age groups diagnosed as having an ovarian mass.
  • Accidentally discovered ovarian mass in non-complaining female.
  • Patients known to have primary that may give metastasis to the ovaries.

You may not qualify if:

  • Patients receive neo adjuvant chemotherapy
  • Recurrent ovarian masses

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine-Assuit Univeristy

Asyut, Egypt

Location

Related Publications (1)

  • Zhang T, Li F, Liu J, Zhang S. Diagnostic performance of the Gynecology Imaging Reporting and Data System for malignant adnexal masses. Int J Gynaecol Obstet. 2017 Jun;137(3):325-331. doi: 10.1002/ijgo.12153. Epub 2017 Apr 12.

    PMID: 28295272BACKGROUND

MeSH Terms

Conditions

Ovarian Neoplasms

Interventions

Ultrasonography

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Neoplasms, FemaleUrogenital NeoplasmsGenital DiseasesEndocrine System DiseasesGonadal Disorders

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Lamiaa M Refaat, Lecturer

    south egypt cancer institue,assuit univeristy

    STUDY DIRECTOR
  • hagar HM Desoky, demonstrator

    south egypt cancer institue,assuit univeristy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle investigator

Study Record Dates

First Submitted

May 29, 2017

First Posted

June 5, 2017

Study Start

July 5, 2018

Primary Completion

February 26, 2019

Study Completion

July 1, 2019

Last Updated

May 12, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Locations